Half-Life of Hydromorphone
The elimination half-life of hydromorphone in healthy adults is approximately 2-3 hours after intravenous administration and 2.3-2.6 hours after oral administration 1.
Pharmacokinetics in Healthy Adults
After intravenous administration, hydromorphone demonstrates the following pharmacokinetic parameters 1, 2:
- Terminal elimination half-life: 2.3 hours (range 2.36-2.64 hours across studies)
- Systemic clearance: approximately 1.96 L/min
- Volume of distribution at steady state: 302.9 L (approximately 2.9-4.2 L/kg)
After oral administration, the half-life remains similar at 2.6 hours 1, with peak plasma concentrations typically achieved within 0.5-1 hour. The oral bioavailability is approximately 24% due to extensive first-pass metabolism 1.
Alterations in Renal Impairment
In patients with renal impairment, hydromorphone elimination is significantly prolonged and drug exposure increases substantially 1:
Moderate Renal Impairment (CrCl 40-60 mL/min):
- Drug exposure (Cmax and AUC) increases 2-fold
- Requires starting at one-fourth to one-half the usual dose 1
Severe Renal Impairment (CrCl <30 mL/min):
- Drug exposure increases 3-fold
- Terminal elimination half-life extends dramatically to approximately 40 hours (compared to 15 hours in normal function) 1
- Requires even more conservative starting doses (one-fourth to one-half usual dose)
- Close monitoring during titration is mandatory
Critical clinical implication: The 17-fold increase in half-life with severe renal impairment means hydromorphone accumulation becomes a significant risk, despite the drug being primarily hepatically metabolized 1. This occurs because the glucuronide metabolites are renally excreted 3.
Recent evidence confirms that intravenous hydromorphone steady-state clearance decreases to approximately 50% of normal in patients with moderate-to-severe renal impairment 4.
Alterations in Hepatic Impairment
In patients with hepatic impairment, hydromorphone exposure increases but the half-life remains relatively stable 5, 1:
Moderate Hepatic Impairment (Child-Pugh B):
- Drug exposure (Cmax and AUC) increases 4-fold
- Half-life is reported to remain stable despite increased exposure 5
- Requires starting at one-fourth to one-half the usual dose with close monitoring 1
Severe Hepatic Impairment:
- Pharmacokinetics have not been formally studied
- Further increases in Cmax and AUC are expected
- Even more conservative starting doses required 1
Important distinction: Unlike morphine (where half-life doubles in cirrhosis), hydromorphone's half-life stability in hepatic dysfunction makes it a preferred choice in this population 5. This is because hydromorphone is metabolized by glucuronidation (Phase II metabolism) rather than cytochrome P450 pathways, and it produces no active metabolites that accumulate 5.
Clinical Recommendations by Organ Dysfunction
For renal impairment: Hydromorphone, morphine, codeine, and oxymorphone should be used with caution due to accumulation of renally cleared metabolites 3. Methadone or fentanyl may be preferred alternatives in severe renal disease 6.
For hepatic impairment: Hydromorphone is recommended as a safer option because its half-life remains stable and it undergoes conjugation metabolism 5. Recent guidelines specifically recommend hydromorphone (along with morphine and paracetamol) while suggesting avoidance of oxycodone, tramadol, and codeine in end-stage liver disease 5.
Key Clinical Pitfalls
- Do not assume the short half-life in healthy adults applies to renally impaired patients - the 40-hour half-life in severe renal dysfunction fundamentally changes dosing requirements
- Monitor for delayed toxicity - steady state may not be reached for several days in renal impairment
- Hepatic impairment increases exposure without proportionally extending half-life - this means higher peak concentrations with similar duration, requiring dose reduction but not necessarily frequency adjustment
- The duration of analgesia (2-3 hours) listed in guidelines 3 reflects clinical effect, not elimination half-life - these are distinct parameters